Prof. Dr. med.; M.Sc. Michael Brändle
Chefarzt
Allgemeine Innere Medizin | Hausarztmedizin und Notfallmedizin, Endokrinologie | Diabetologie | Osteologie | Stoffwechselerkrankungen · Dept. I
Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease
Clerici T, Brändle M, Lange J, Doherty G, Gauger P. Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease. World journal of surgery 2004; 28:187-92.
01.02.2004Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease
01.02.2004World journal of surgery 2004; 28:187-92
Clerici Thomas, Brändle Michael, Lange Jochen, Doherty Gerard M, Gauger Paul G
A novel succinate dehydrogenase subunit B gene mutation, H132P, causes familial malignant sympathetic extraadrenal paragangliomas
Maier M, Schmid C, Galeazzi R, Krull I, Heitz P, Locher T, Schmid S, Saremaslani P, Komminoth P, Brändle M, Perren A. A novel succinate dehydrogenase subunit B gene mutation, H132P, causes familial malignant sympathetic extraadrenal paragangliomas. The Journal of clinical endocrinology and metabolism 2004; 89:362-7.
01.01.2004A novel succinate dehydrogenase subunit B gene mutation, H132P, causes familial malignant sympathetic extraadrenal paragangliomas
01.01.2004The Journal of clinical endocrinology and metabolism 2004; 89:362-7
Maier Margarete, Schmid Christoph, Galeazzi Renato L, Krull Ina, Heitz Philipp U, Locher Tamara, Schmid Sonja, Saremaslani Parvin, Komminoth Paul, Brändle Michael, Perren Aurel
Effect of thyroxine replacement on creatinine, insulin-like growth factor 1, acid-labile subunit, and vascular endothelial growth factor
Schmid C, Brändle M, Zwimpfer C, Zapf J, Wiesli P. Effect of thyroxine replacement on creatinine, insulin-like growth factor 1, acid-labile subunit, and vascular endothelial growth factor. Clinical chemistry 2004; 50:228-31.
01.01.2004Effect of thyroxine replacement on creatinine, insulin-like growth factor 1, acid-labile subunit, and vascular endothelial growth factor
01.01.2004Clinical chemistry 2004; 50:228-31
Schmid Christoph, Brändle Michael, Zwimpfer Cornelia, Zapf Jürgen, Wiesli Peter
Opportunistic screening for diabetes in routine clinical practice
Ealovega M, Tabaei B, Brändle M, Burke R, Herman W. Opportunistic screening for diabetes in routine clinical practice. Diabetes care 2004; 27:9-12.
01.01.2004Opportunistic screening for diabetes in routine clinical practice
01.01.2004Diabetes care 2004; 27:9-12
Ealovega Mark W, Tabaei Bahman P, Brändle Michael, Burke Ray, Herman William H
The direct medical cost of type 2 diabetes
Brändle M, Zhou H, Smith B, Marriott D, Burke R, Tabaei B, Brown M, Herman W. The direct medical cost of type 2 diabetes. Diabetes care 2003; 26:2300-4.
01.08.2003The direct medical cost of type 2 diabetes
01.08.2003Diabetes care 2003; 26:2300-4
Brändle Michael, Zhou Honghong, Smith Barbara R K, Marriott Deanna, Burke Ray, Tabaei Bahman P, Brown Morton B, Herman William H
Extensive spherical amyloid deposition presenting as a pituitary tumor
Wiesli P, Brändle M, Brandner S, Kollias S, Bernays R. Extensive spherical amyloid deposition presenting as a pituitary tumor. Journal of endocrinological investigation 2003; 26:552-5.
01.06.2003Extensive spherical amyloid deposition presenting as a pituitary tumor
01.06.2003Journal of endocrinological investigation 2003; 26:552-5
Wiesli P, Brändle Michael, Brandner S, Kollias S S, Bernays R L
Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes
Brändle M, Davidson M, Schriger D, Lorber B, Herman W. Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes care 2003; 26:1796-801.
01.06.2003Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes
01.06.2003Diabetes care 2003; 26:1796-801
Brändle Michael, Davidson Mayer B, Schriger David L, Lorber Brett, Herman William H
Impact of thyroid dysfunction on serum cystatin C
Fricker M, Wiesli P, Brändle M, Schwegler B, Schmid C. Impact of thyroid dysfunction on serum cystatin C. Kidney international 2003; 63:1944-7.
01.05.2003Impact of thyroid dysfunction on serum cystatin C
01.05.2003Kidney international 2003; 63:1944-7
Fricker Manuel, Wiesli Peter, Brändle Michael, Schwegler Beat, Schmid Christoph
Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program
Hernan W, Brändle M, Zhang P, Williamson D, Matulik M, Ratner R, Lachin J, Engelgau M, Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes care 2003; 26:36-47.
01.01.2003Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program
01.01.2003Diabetes care 2003; 26:36-47
Hernan William H, Brändle Michael, Zhang Ping, Williamson David F, Matulik Margaret J, Ratner Robert E, Lachin John M, Engelgau Michael M, Diabetes Prevention Program Research Group
A plasma glucose concentration below 2.5 mmol L-1 is not an appropriate criterion to end the 72-h fast
Wiesli P, Brändle M, Schwegler B, Lehmann R, Spinas G, Schmid C. A plasma glucose concentration below 2.5 mmol L-1 is not an appropriate criterion to end the 72-h fast. Journal of internal medicine 2002; 252:504-9.
01.12.2002A plasma glucose concentration below 2.5 mmol L-1 is not an appropriate criterion to end the 72-h fast
01.12.2002Journal of internal medicine 2002; 252:504-9
Wiesli P, Brändle Michael, Schwegler B, Lehmann R, Spinas G A, Schmid C
Valuing health-related quality of life in diabetes
Coffey J, Brändle M, Zhou H, Marriott D, Burke R, Tabaei B, Engelgau M, Kaplan R, Herman W. Valuing health-related quality of life in diabetes. Diabetes care 2002; 25:2238-43.
01.12.2002Valuing health-related quality of life in diabetes
01.12.2002Diabetes care 2002; 25:2238-43
Coffey J Todd, Brändle Michael, Zhou Honghong, Marriott Deanna, Burke Ray, Tabaei Bahman P, Engelgau Michael M, Kaplan Robert M, Herman William H
[Diabetic ketoacidosis and hyperosmolar hyperglycemia. 24 consecutive cases]
Vavricka S, Walter R, Brändle M, Ballmer P, Haller A. [Diabetic ketoacidosis and hyperosmolar hyperglycemia. 24 consecutive cases]. Deutsche medizinische Wochenschrift (1946) 2002; 127:2441-6.
15.11.2002[Diabetic ketoacidosis and hyperosmolar hyperglycemia. 24 consecutive cases]
15.11.2002Deutsche medizinische Wochenschrift (1946) 2002; 127:2441-6
Vavricka S R, Walter R B, Brändle Michael, Ballmer P E, Haller A
[Management of cardiovascular risk factors in type 2 diabetes mellitus]
Brändle M, Spinas G. [Management of cardiovascular risk factors in type 2 diabetes mellitus]. Therapeutische Umschau. Revue thérapeutique 2002; 59:415-21.
01.08.2002[Management of cardiovascular risk factors in type 2 diabetes mellitus]
01.08.2002Therapeutische Umschau. Revue thérapeutique 2002; 59:415-21
Brändle Michael, Spinas G A
Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours
Brändle M, Pfammatter T, Spinas G, Lehmann R, Schmid C. Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours. Clinical endocrinology 2001; 55:357-62.
01.09.2001Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours
01.09.2001Clinical endocrinology 2001; 55:357-62
Brändle Michael, Pfammatter T, Spinas G A, Lehmann R, Schmid C
Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation
Brändle M, Lehmann R, Maly F, Schmid C, Spinas G. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation. Diabetes care 2001; 24:1253-8.
01.07.2001Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation
01.07.2001Diabetes care 2001; 24:1253-8
Brändle Michael, Lehmann R, Maly F E, Schmid C, Spinas G A
10 Swiss kindreds with multiple endocrine neoplasia type 1: assessment of screening methods
Clerici T, Schmid C, Komminoth P, Lange J, Spinas G, Brändle M. 10 Swiss kindreds with multiple endocrine neoplasia type 1: assessment of screening methods. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:381-6.
30.06.200110 Swiss kindreds with multiple endocrine neoplasia type 1: assessment of screening methods
30.06.2001Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:381-6
Clerici Thomas, Schmid C, Komminoth P, Lange Jochen, Spinas G A, Brändle Michael
Reactive hypoglycaemia due to late dumping syndrome: successful treatment with acarbose
Imhof A, Schneemann M, Schaffner A, Brändle M. Reactive hypoglycaemia due to late dumping syndrome: successful treatment with acarbose. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:81-3.
10.02.2001Reactive hypoglycaemia due to late dumping syndrome: successful treatment with acarbose
10.02.2001Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:81-3
Imhof A, Schneemann M, Schaffner A, Brändle Michael
[Type 2A multiple endocrine neoplasia with cutaneous lichen amyloidosis]
Brändle M, Schlaeppi M, Schmid C. [Type 2A multiple endocrine neoplasia with cutaneous lichen amyloidosis]. Schweiz Med Wochenschr 2000; 130:861.
03.06.2000[Type 2A multiple endocrine neoplasia with cutaneous lichen amyloidosis]
03.06.2000Schweiz Med Wochenschr 2000; 130:861
Brändle Michael, Schlaeppi Marc, Schmid C
Galactorrhoea and pituitary mass: a typical prolactinoma?
Brändle M, Schmid C. Galactorrhoea and pituitary mass: a typical prolactinoma?. Postgraduate medical journal 2000; 76:232-4.
01.04.2000Galactorrhoea and pituitary mass: a typical prolactinoma?
01.04.2000Postgraduate medical journal 2000; 76:232-4
Brändle Michael, Schmid C
[Cushing syndrome due to ectopic ACTH secretion: an uncommon case presentation, diagnosis and therapy]
Eggenberger C, Brändle M, Galeazzi R, Spinas G, Schmid C. [Cushing syndrome due to ectopic ACTH secretion: an uncommon case presentation, diagnosis and therapy]. Schweizerische medizinische Wochenschrift 1999; 129:890-5.
12.06.1999[Cushing syndrome due to ectopic ACTH secretion: an uncommon case presentation, diagnosis and therapy]
12.06.1999Schweizerische medizinische Wochenschrift 1999; 129:890-5
Eggenberger C, Brändle Michael, Galeazzi R L, Spinas G A, Schmid C